BAXTER HEALTHCARE CORPORATION for BAXTER HEALTHCARE CORPORATION
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Trade issues with China
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH V SCHWAN New | Deputy Chief of Staff, U.S. Dept of Commerce |
Medicare/Medicaid MMM
H.R.1: The American Recovery and Reinvestment Act (stimulus bill); Specifically focused on aspects of the bill related to comparative effectiveness research. H.R.1548 : To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes. S.547 : A bill to amend title XIX of the Social Security Act to reduce the costs of prescription drugs for enrollees of Medicaid managed care organizations by extending the discounts offered under fee-for-service Medicaid to such organizations. H.R.1765 : To amend title XVIII of the Social Security Act with respect to payment for the furnishing of intravenous immune globulin (IVIG) in a patient's home for the treatment of primary immune deficiency diseases and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare Program. H.R.1085/S. 442: To impose a limitation on lifetime aggregate limits imposed by health plans. Drug and biological product pricing and reimbursement Product Payment Issues Therapy Payment Issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH CREVISTON | — |
| JACK MANIKO New | Counsel, House Cmte on Energy & Commerce |
| KELLI MILLS LESTER | — |
| JED PERRY New | — |
| JOSEPH V SCHWAN New | Deputy Chief of Staff, U.S. Dept of Commerce |
| DEBORAH WILLIAMS | Prof. Staff, House Committe on Ways & Means |
Labor Issues/Antitrust/Workplace LBR
H.R. 1409/S. 560: To amend the National Labor Relations Act to establish an efficient system to enable employees to form, join, or assist labor organizations, to provide for mandatory injunctions for unfair labor practices during the organizing efforts, and for other purposes
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH V SCHWAN New | Deputy Chief of Staff, U.S. Dept of Commerce |
Taxation/Internal Revenue Code TAX
H.R. 1, American Recovery and Reinvestment Act of 2009, as it relates to the taxation of foreign earnings of U.S. multinational corporations. H. Con Res. 85 and S. Con Res. 13, setting forth the congressional budget for the U.S. Governoment for FY 2010, as it relates to the taxation for foreign earnings of U.S. multinational corporations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH V SCHWAN New | Deputy Chief of Staff, U.S. Dept of Commerce |
Copyright/Patent/Trademark CPT
S.515/H.R. 1260: Patent Reform Act of 2009
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH CREVISTON | — |
| JED PERRY New | — |
| JOSEPH V SCHWAN New | Deputy Chief of Staff, U.S. Dept of Commerce |
Health Issues HCR
H.R. 6331 (110th Congress): To amend titles XVIII and XIX of the Social Security Act to extend expiring provisions under the Medicare Program, to improve beneficiary access to preventive and mental health services, to enhance low-income benefit programs, and to maintain access to care in rural areas, including pharmacy access, and for other purposes. In particular, execution of the kidney education and bundling provisions. H.R.1: The American Recovery and Reinvestment Act (stimulus bill); Specifically focused on aspects of the bill related to comparative effectiveness research. H.R.1548 : To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes. S.547 : A bill to amend title XIX of the Social Security Act to reduce the costs of prescription drugs for enrollees of Medicaid managed care organizations by extending the discounts offered under fee-for-service Medicaid to such organizations. H.R.1765 : To amend title XVIII of the Social Security Act with respect to payment for the furnishing of intravenous immune globulin (IVIG) in a patient's home for the treatment of primary immune deficiency diseases and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare Program. H.R.1085/S. 442: To impose a limitation on lifetime aggregate limits imposed by health plans Drug and device marketing and promotion Drug and biological product pricing and reimbursement Healthcare-acquired infections Lifetime caps for insurance Medical product safety Prescription drug pedigree and anti-counterfeiting policy
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH CREVISTON | — |
| JACK MANIKO New | Counsel, House Cmte on Energy & Commerce |
| KELLI MILLS LESTER | — |
| JED PERRY New | — |
| JOSEPH V SCHWAN New | Deputy Chief of Staff, U.S. Dept of Commerce |
| DEBORAH WILLIAMS | Prof. Staff, House Committee on Ways & Means |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.